
The unprecedented pace of therapeutic development in zzso has created a climate in which the traditional methods of evaluating agent activity might no longer be zzso How is the field transitioning to new zzso in early drug development and what are the difficulties in this zzso Here, we will explore the historical context for the current criteria for zzso response evaluation and some of the pitfalls in using these standards when testing newer zzso agents for zzso We will argue that the current drug development environment dictates different outcome zzso and therefore more imaginative and rigorous zzso trial zzso 

